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Abstract
The contributions of fiber atrophy, fiber loss, in situ specific force, and voluntary activation to weakness in sarcopenia remain unclear. To 
investigate, 40 older (20 women; age 72 ± 4 years) and 31 younger adults (15 women, age 22 ± 3 years) completed measurements. The knee 
extensor maximal voluntary torque (MVC) was measured as well as voluntary activation, patella tendon moment arm length, muscle volume, 
and fascicle architecture to estimate in situ specific force. Fiber cross-sectional area (FCSA), fiber numbers, and connective tissue contents were 
also estimated from vastus lateralis biopsies. The MVC, quadriceps volume, and specific force were 39%, 28%, and 17% lower, respectively, 
in old compared with young, but voluntary activation was not different. The difference in muscle size was due in almost equal proportions to 
lower type II FCSA and fewer fibers. Five years later (n = 23) the MVC, muscle volume and voluntary activation in old decreased an additional 
12%, 6%, and 4%, respectively, but there was no further change in specific force. In situ specific force declines relatively early in older age 
and reduced voluntary activation occurs later, but the overall weakness in sarcopenia is mainly related to loss of both type I and II fibers and 
type II fiber atrophy.
Keywords: Muscles, Sarcopenia, Frailty.
Skeletal muscle weakness is a key feature of sarcopenia (1) and a 
core component of the physical frailty phenotype (2). Weakness 
increases the effort required to complete everyday physical tasks and 
is associated with a higher risk of falling, disability, hospital admis-
sion, and mortality (3). To develop effective countermeasures, it is 
important to understand the factors contributing to weakness.
In young adults, a close relationship exists between muscle cross-
sectional area and the maximal force produced by that muscle (4,5). 
During ageing the muscle mass declines in part due to type II fiber 
atrophy (6,7), which contributes to muscle weakness. Fiber losses 
may also contribute to low muscle mass, although there is surpris-
ingly little data on this matter and conflicting reports with one sug-
gesting fibers are lost with ageing (8) and another stating they are 
not (9). Irrespective of the reasons why muscle mass declines, recent 
reports argue that the relationship between muscle mass and max-
imal force is weak in older adults (10,11). This viewpoint is based 
on the apparent disparity in the age-related changes of maximal 
force and lean mass seen in cross-sectional studies (12,13) and lon-
gitudinal studies where a threefold greater decline of maximal force 
compared to appendicular lean mass has been reported (eg, (14,15)). 
It might be concluded, therefore, that low muscle mass is not the 
primary cause of weakness in older age and this has led to interest in 
possible changes in “muscle quality”, measured as maximal force per 
unit muscle mass (eg, see (13,14,16–18)). However, this literature 
has two important limitations. First, it is strongly influenced by stud-
ies using dual-energy X-ray absorptiometry (DXA) to estimate the 
muscle size. Additionally, they did not consider potentially import-
ant physiological and anatomical contributions to force production, 
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including activation of the motor unit pool, muscle architecture, and 
joint structures.
To understand the causes of weakness in older age, it is neces-
sary to take account of several factors. First, the maximal muscle 
force depends on all available motor units of the agonist muscles 
being fully activated (19). Secondly, muscle force is proportional 
to the number of fibers (or, sarcomeres) in parallel, represented by 
the physiological cross-sectional area (PCSA), rather than the ana-
tomical CSA, of the agonist muscles (20). Thirdly, muscle and joint 
architecture influence the external torque because the tendon force 
decreases in proportion to the cosine of the fiber pennation angle, 
while external torque increases proportionately with the tendon 
moment arm (20). Considering all of these factors together gives 
a better estimate of muscle quality than just normalizing maximal 
force to lean mass derived from DXA, and is referred to here as 
in situ specific force. Previous studies showed lower in situ specific 
force of plantar flexors (21) and voluntary activation of knee exten-
sors (19) in old compared with young. However, there is currently 
limited information about specific force and voluntary activation of 
sarcopenic muscle and no information about longitudinal changes in 
specific force for older adults.
The aim of the present study was to estimate the contributions of 
muscle size and specific force to the maximal external muscle torque 
in young and older adults. The hypothesis was that low muscle mass 
as well as reduced voluntary activation and in situ specific force con-
tribute to weakness in sarcopenia. Following on from this, we aimed 
to estimate the contributions of muscle fiber atrophy and muscle 
fiber loss to the overall quadriceps muscle atrophy with ageing. These 
aims were addressed through comparison of results from young and 
older adults and a longitudinal examination of older adults.
Methods
Ethical Approval and Research Participants
The Local Research Ethics Committee approved the study. All volun-
teers provided written informed consent. Volunteers were excluded 
if they were involved in any competitive sports (recreational sports 
were allowed) or had cardiovascular (controlled hypertension was 
allowed), metabolic, musculoskeletal, neurological or mental condi-
tions, or body mass index <18 or >32 kg/m2.
Participants arrived at the research facility between 9 am and 10 am. 
DXA and magnetic resonance images (MRI) were collected, fol-
lowed by the grip strength, timed-up-and-go, and 6-min walk tests. 
A light snack and drink were provided and after a 30-min break, the 
assessments of knee extensor voluntary activation and architecture 
were completed. For longitudinal studies, the older participants were 
invited to complete the same assessments 5  years later. Participant 
characteristics are shown in Table 1, including results for the basic 
functional assessments of 6 min walk test (walking as far as possible 
in 6 min around cones placed 20 m apart), maximal grip strength 
(Jamar dynamometer performed twice on each hand and the max-
imum value taken), and timed up and go (TUG: starting from a 
seated position, stand, and walk around a cone placed 3 m in front 
and then return to the original seated position), which were all per-
formed following standardized procedures described previously (22).
Musculoskeletal Imaging
Participants were scanned by DXA (Lunar prodigy advance, GE 
Healthcare, Chalfont St Giles, UK) after an overnight fast in the 
supine position whilst wearing a light cotton robe. Offline analysis 
(encore 2006 v 10.50.086) identified whole body lean mass and Ta
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body fat percentage, arm and leg lean mass, and bone mineral con-
tent (22). Appendicular lean mass muscle mass (ALMM) was cal-
culated as: [(lean mass of legs + lean mass of arms) – (bone mineral 
content of legs + bone mineral content of arms)] (14).
A 0.25-T MRI scanner (G-scan, Esaote Biomedica, Genoa, Italy) 
was used to collect transverse plane sections (Turbo-3D T1-weighted 
protocol with consecutive 2.8  mm thick slices) from the dominant 
leg tibial tubercle through to the anterior–inferior iliac spine with 
participants in the supine position (23). Osirix imaging software was 
used to estimate the anatomical cross-sectional areas of each of the 
four heads of the quadriceps muscles from transverse plane images at 
25 mm intervals from the distal to the proximal ends of the quadri-
ceps. These cross-sectional areas were summed and multiplied by the 
distance between slices (2.5 cm) to estimate quadriceps muscle vol-
ume. The patella tendon moment arm was imaged with the leg at full 
extension and estimated from sagittal plane slices as the distance from 
the mid-contact point between the femoral condyles and tibial plateau 
to the patella tendon. The moment arm length was multiplied by 0.99 
to adjust for the difference between full knee extension to 90° flexion 
(24) [the angle at which maximal voluntary contraction (MVC) was 
measured] and the resulting value was multiplied by 1.14 to adjust for 
the 14% increase in moment arm in transition from rest to MVC (25). 
This technique has a coefficient of variation of <4% (26).
MVC and Voluntary Activation
A custom-built isometric dynamometer was used to assess knee 
extension MVC torque of the dominant leg with participants sitting 
with the knee and hip angles at 90°. A strap was firmly secured across 
the hip joint and the lower leg securely strapped to the force trans-
ducer 2 cm above the malleolus. The linear distance from the esti-
mated centre of knee rotation to the point of force application (2 cm 
above the malleolus) was taken as the lever length (m). Torque was 
estimated as force multiplied by lever length. Force signals sampled at 
2000 Hz were digitized for real-time visual display and for recording 
on a computer interface running Labview and a customized Matlab 
script (Matlab, the Mathwork Inc., S Natik, MA). Participants were 
familiarized with the knee extension exercise by performing up to 
five contractions at around 50% of maximal effort each lasting 3 s, 
and another two contractions at around 80% maximal effort. After a 
2-min rest, participants performed a maximal isometric contraction, 
sustained for 3 s with visual feedback, and strong verbal encourage-
ment and this was repeated a further two times. The highest recorded 
torque was taken as MVC. The patella tendon force was estimated 
from the moment equilibrium equation around the knee joint (27) by 
dividing the MVC torque by the patella tendon moment arm length. 
Voluntary activation was assessed using a version of the interpo-
lated twitch technique (28,29) with stimulating electrodes covering 
the proximal and distal portions of the quadriceps (AmericanImex: 
Dispersive electrode, 4 × 7 inch), connected to a Digitimer DS7AH 
set at 400 V (Welwyn Garden City, UK) and current increased to 
deliver supramaximal “doublet” (two 200-μs pulses separated by 
10 ms) stimuli over the quadriceps muscle group. Stimulation was 
applied to the relaxed muscle 1  s prior to a maximal voluntary 
effort and then again at the highest point of the MVC. In the cross-
sectional study, a third doublet was also applied 2 s after the MVC. 
The voluntary activation test was performed twice and the result 
giving the highest voluntary activation was accepted. The percentage 
voluntary activation was calculated as:
 % ( / ) voluntary activation 1 1= × −00 t T
Where t was the amplitude of the superimposed doublet (ie, the 
size of the additional peak) and T the value of the doublet applied to 
the resting muscle 1 s prior to MVC.
Physiological Cross-Sectional Area (PCSA) and In 
Situ Specific Force
Physiological cross-sectional area was calculated for each quadri-
ceps muscle as: [muscle volume/fascicle length], and the sum taken 
as quadriceps PCSA (30).
The fascicle length and pennation angle used in these calcula-
tions were estimated using real-time B-mode Ultrasonography with 
a 7.5-MHz linear array probe. Measurements were collected at the 
mid belly of each of the four heads of the quadriceps muscles in the 
sagittal plane at the moment of peak force during MVC contrac-
tions (26). Imaging software (Image J; v1.39b; National Institutes of 
Health, Bethesda, MA) was used to determine muscle fascicle length 
from the superficial to the deep aponeurosis. Pennation angle was 
determined as the angle at which the fascicles intercepted the deep 
aponeurosis. Thickness was measured as the perpendicular distance 
between the superficial and deep aponeurosis.
For calculations of in situ specific force, the quadriceps PCSA 
was multiplied by the cosine of the fascicle pennation angle to 
account for the reduction in transmission of forces from fibers to 
aponeurosis to adjust for the angle between the fascicles and the line 
of pull through the patella tendon. Specific force was estimated as: 
[(external torque/moment arm)/(PCSA * pennation angle)] or simpli-
fied to: [Patella tendon force/(PCSA * pennation angle)] (26). The 
external force used in the calculation of specific force was the “true 
MVC”, which is the estimated MVC if full voluntary activation was 
possible: True MVC = MVC immediately prior to the superimposed 
doublet/(1 – t/T). Where t was the amplitude of the superimposed 
doublet (ie, the size of the additional peak) and T the value of the 
doublet applied to the resting muscle 1 s prior to MVC.
Muscle Morphology
Muscle biopsies available from young and old participants were taken 
using a conchotome from midway along the length of the right vastus 
lateralis muscle (VL) under aseptic conditions and local anesthesia (1% 
lignocaine). The samples were placed on cork with fibers running ver-
tically and immediately frozen in liquid nitrogen whilst shaking vigor-
ously to avoid freezing artifacts. Muscle sections were stained for myosin 
ATPase activity after preincubation at pH 4.35 to identify type I and 
type II fibers and determination of the fiber cross-sectional areas (FCSA). 
Serial sections were stained with Sirius Red to assess the collagen content 
and analysed using a customized Matlab programme. The total numbers 
of fibers in the VL PCSA was estimated as: [VL PCSA/average FCSA]. 
Biopsies were not collected in the longitudinal follow-up study.
Statistical Analysis
The Shapiro–Wilk test showed that all data were normally distrib-
uted. A two-way ANOVA was used to test for age and gender effects 
of outcome parameters. Pearson’s Product Moment Correlations were 
used to assess the relationship between variables. Changes occurring 
over the 5-year follow-up period were assessed using paired samples 
t-tests. Two stepwise multiple regression models were used to identify 
factors associated with MVC torque: the first for baseline and the sec-
ond for follow-up changes. Both included quadriceps volume, volun-
tary activation, VL fascicle pennation angle, patella tendon moment 
arm length, age, and gender. The second model was adapted to exam-
ine predictors of longitudinal changes in MVC torque and used the 
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percentage changes in each of these variables. Standardized beta coef-
ficients (β) indicate the change in standard deviation of MVC torque 
per standard deviation change in the independent variable. Statistical 
testing was completed using SPSS (IBM v.23.) and significance was 
accepted as p < .05. Results are reported as mean and standard devi-
ation (SD), unless otherwise stated.
Results
Muscle Size, Strength, and Specific Force
Table 1 provides the data for grip strength, TUG, and 6-min walk, 
as well as ALMM and ALMM/h2 and the data show the older adults 
to be sarcopenic. There were no significant age × gender interac-
tions for any of the measurements, indicating that the effects of age 
described here apply similarly to men and women.
The MVC torque (Figure  1A) and peak patella tendon force 
(Figure 1B) in old were 37% and 39%, respectively, lower than val-
ues for young. Quadriceps PCSA was 25% lower in old than young 
(Figure 1C) and was positively correlated (R2 = 0.598; p < .001) with 
tendon force (Figure 1D). The in situ specific force value for old was 
83% of values for young (Figure 2; p < .001).
During the 5  years of follow-up, components of sarcopenia 
including ALMM and performance in the TUG and 6-min walk tests 
all decreased (Table 1). The percentage decrease from baseline values 
included 12% (±13) lower MVC torque, 6% (±9) lower quadriceps 
muscle volume, 5% (±9) lower PCSA, and 4% (±6) lower voluntary 
activation (all p < .05), but the in situ specific force did not change 
significantly (3% (±11); Figure 3).
Predictors of MVC Torque
The regression model based on data from young and old explained 
83% of the variation in external torque. The majority was due 
to quadriceps volume (adjusted R2  = 0.765; β  = 0.727; p < .001) 
and a small contribution of age (adjusted R2 = 0.057; β = −0.286; 
p  <  0.001). Gender, pennation angle, voluntary activation, and 
moment arm length did not contribute significantly to the model. 
A similar result was found if quadriceps PCSA was used in the model 
rather than quadriceps muscle volume. The remaining 17% of the 
variation in external torque not explained by any variables in this 
model includes the contribution of muscle specific force.
The regression model based on longitudinal data explained 
72% of the change in external torque, with the main factor being 
change in quadriceps volume (adjusted R2 = 0.510; β = 0.730; p < 
.001) and a contribution of change in voluntary activation (adjusted 
R2 = 0.210; β = −0.460; p = .001). Gender, age, pennation angle, and 
moment arm length did not contribute significantly to the model.
Muscle Fiber Cross-Sectional Area and Estimated 
Fiber Numbers per PCSA
Since the results comparing young with old and the longitudinal 
study point towards loss of muscle mass being the main determinant 
of low MVC torque in older age, additional analysis was completed 
to determine the relative contributions of fiber atrophy and fiber loss 
to the difference between young and old in VL PCSA.
The relative area occupied by type I and type II fibers did not differ 
significantly between young and old (p = .423) or between men and 
women (p = .726) (type I: young men: 38.8 ± 11.7; young women: 
37.3 ± 8.8; older men: 42.0 ± 12.8; older women: 40.8 ± 7.4%).
Figure  1. Knee extensor size and strength measurements in young and 
older men and women. (A) Knee extensor MCV torque; (B) MVC patella 
tendon force; (C) quadriceps physiological cross-sectional area (PCSA); (D) 
the relationship between patella tendon force and quadriceps PCSA for 
young (shaded circles, continuous line) and older (filled circles, dashed 
line) adults. Data shown as mean ± SD (A–C) and individual data points (D). 
MVC  =  maximal voluntary contraction; PCSA  =  quadriceps physiological 
cross sectional area; OM = older men; OW = older women; YM = young men; 
YW = young women. p values indicate the results of a two-way ANOVA; age 
× gender interactions were not significant for any of these measurements. 
Figure  2. Knee extensor in situ specific force. Data shown as mean ± SD. 
OM = older men; OW = older women; YM = young men; YW = young women. 
p values indicate the results of a two-way ANOVA; there was no significant 
age × gender interaction. 
Figure 3. Five-year changes to muscle torque, size, activation, and specific 
force. Data from older adults only and shown as mean ± SD. P-value indicates 
significance of change from baseline.
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There was no significant difference between young and old in 
type I FCSA (p = .487), but type II fibers had 26% lower FCSA in 
old (p < .001; Table  2). Considering the type I  and type II fibers 
together, the overall FCSA was 15% lower in old than young, which 
would give approximately 9.5  cm2 smaller VL PCSA in old than 
young. However, the actual VL PCSA was 17.5 cm2 (28%) smaller 
in old than young, suggesting that fiber atrophy alone accounts for 
approximately 54% of the overall muscle atrophy and the remainder 
(46%) is due to old having fewer fibers than young. The estimated 
numbers of muscle fibers per VL PCSA (PCSA divided by FCSA) 
was 1.22 million in young and 1.03 million (15% fewer) in old. 
The old had a higher proportion of connective tissue than young 
(11.3 ± 1.0% in young and 14.2 ± 1.4% in old). Taking into account, 
this 3% difference reduces the estimated number of fibers per VL 
PCSA to 1 million in old, which is 18% fewer than the young.
Discussion
We have considered muscle quantity, quality, and activation to under-
stand the causes of muscular weakness (sometimes referred to as 
dynapenia) in sarcopenia. The results show that 28% lower muscle 
mass was the main cause of weakness in old compared with young 
and a further decrease in muscle mass was the main predictor of pro-
gressing weakness over the follow-up period. In situ specific force was 
17% lower in old compared with young and did not decrease fur-
ther during the follow-up period. Voluntary activation was similar for 
young and old, but the 4% decrease over 5 years of follow-up contrib-
uted to the declining MVC torque. The lower muscle mass in older age 
was due in about equal proportions to fiber atrophy and loss of fibers.
Knee Extensor Torque and Size
Low muscle mass is the criterion measurement for sarcopenia and 
can be estimated as ALM/h2. The average ALM/h2 of 6.9 kg/m2 for 
older men and 5.1 kg/m2 for older women at baseline were below 
the recommended sarcopenia cut-off values of 7.26 kg/m2 for men 
and 5.5  kg/m2 for women (1). Components of sarcopenia further 
declined at follow-up (Table 1). In the results comparing young with 
older adults there was a 26–28% lower muscle size (PCSA and vol-
ume, respectively) and 37% lower MVC torque. If we assume muscle 
declines begin from age 30 years (13,18,31,32), the rate of change is 
estimated to be 0.9, 0.7, and 0.4% per year, respectively, for MVC 
torque, quadriceps size and in situ specific force. A  further 12% 
decline in MVC was observed over the 5-year follow-up of the older 
adults. This rate of decline is more than twice that estimated for the 
previous 40 years and is generally in agreement with the literature 
highlighting accelerated deterioration with advancing older age (33).
Our results suggest that the cause of muscle weakness during 
ageing to around age 70 years is due to loss of muscle mass and, to a 
lesser extent, specific force. An important novel finding of the present 
study was that the further weakening into the late 70s is primarily 
attributable to continued decline of muscle mass and a lower volun-
tary activation.
In Situ Specific Force
Recent reports suggest that muscle quality is the major determinant 
of strength in older age (10,11). This literature is largely based on 
DXA studies to estimate lean mass, where only weak relationships 
are seen with MVC torque or force (10,11,13). These studies using 
DXA do not measure the agonist muscle size and in this respect, 
the MRI is the criterion technique and computed tomography (CT) 
is also preferable to DXA (34). Our results using MRI do not sup-
port the literature stating a large discordance between muscle mass 
and strength in older adults. Rather, a positive relationship exists 
between quadriceps PCSA and patella tendon force in young and old 
(Figure 1), which is in keeping with the long-standing literature from 
MRI and CT imaging (4,5,35–38).
A large-scale longitudinal observation of muscle quality that 
included an accurate (CT) measurement of muscle size showed 
around 5% loss of thigh muscle CSA and 16% decrease in MVC force 
over 5 years in older men and women (39). This disproportionate 
Table 2. Skeletal Muscle Characteristics
YM
(n = 16)
YW
(n = 15)
OM
(n = 20)
OW
(n = 20)
p Value: 
Gender
p Value:  
Age
O versus Y 
(%)
Voluntary activation (%) 90.1 ± 3.7 92.2 ± 3.8 88.5 ± 5.9 90.9 ± 5.1 .073 .252 −1
Moment arm (cm) 4.0 ± 0.2 3.3 ± 0.3 4.0 ± 0.3 3.4 ± 0.3 <.001 .447 3
R. leg lean mass (kg) 10.3 ± 1.0 6.5 ± 0.8 8.8 ± 1.6 5.6 ± 0.8 <.001 <.001 −14
R. quads mass (kg) 2.2 ± 0.3 1.4 ± 0.2 1.6 ± 0.3 1.1 ± 0.2 <.001 <.001 −28
VL fascicle length (mm) 90.6 ± 11.3 86.6 ± 12.0 95.0 ± 13.9 88.4 ± 10.1 .073 .290 4
VL pennation angle (deg) 15.3 ± 2.9 13.8 ± 1.8 12.3 ± 2.1 11.9 ± 1.4 .061 <.001 −17
VL thickness (mm) 25.2 ± 3.2 19.9 ± 2.9 20.4 ± 3.5 17.9 ± 2.8 <.001 <.001 −15
VI fascicle length (mm) 100.5 ± 11.0 92.5 ± 10.5 93.3 ± 12.6 87.4 ± 11.2 .014 .028 −6
VI pennation angle (deg) 12.0 ± 2.5 10.9 ± 2.0 11.9 ± 2.7 10.5 ± 1.7 .025 .699 −2
VI thickness (mm) 21.1 ± 4.9 18.2 ± 4.0 19.0 ± 3.1 15.9 ± 3.6 .002 .026 −11
RF fascicle length (mm) 76.7 ± 16.0 70.7 ± 10.8 78.3 ± 20.0 71.9 ± 19.7 .150 .738 2
RF pennation angle (deg) 19.2 ± 4.0 18.0 ± 2.4 15.6 ± 3.1 14.9 ± 2.7 .084 <.001 −20
RF thickness (mm) 23.6 ± 4.2 19.9 ± 4.0 20.4 ± 4.3 17.8 ± 5.0 .005 .015 −12
VM fascicle length (mm) 94.7 ± 13.1 74.1 ± 15.9 87.5 ± 12.0 74.9 ± 17.7 <.001 .375 −4
VM pennation angle (deg) 20.8 ± 4.3 19.5 ± 7.2 19.6 ± 3.2 15.3 ± 2.7 .011 .014 −13
VM thickness (mm) 31.3 ± 5.1 21.5 ± 3.4 26.6 ± 4.2 19.3 ± 4.8 <.001 .002 −13
Type I FCSA (µm2) 4,880 ± 690 4,180 ± 920 5,230 ± 1,940 4,160 ± 1,190 .708 .487 4
Type II FCSA (µm2) 6,110 ± 1,330 4,600 ± 650 5,000 ± 1,440 2,960 ± 500 <.001 <.001 −26
Note: Data shown as mean ± SD. FCSA = fiber cross-sectional area (available from 13 young men, 8 young women, 20 older men, and 10 older women); 
OM = older men; OW = older women; RF = rectus femoris; VL = vastus lateralis; VI = vastus intermedius; VM = vastus medialis; YM = young men; YW = young 
women.
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loss of strength compared to mass was interpreted as reduced muscle 
quality being the decisive factor for weakness (39). However, with-
out a measurement of the neural activation, these findings alone 
should not be interpreted in this way because strength can decline 
due to subjects being less willing to perform a maximum contrac-
tion or less able to activate the motor unit pool, as we have dem-
onstrated in our results and others have previously shown (19,40). 
We calculated voluntary activation using the superimposed doublet 
normalized to the pre-MVC doublet, based on the assumption that 
the superimposed stimulus activates motor units (muscle fibers) not 
recruited during the voluntary effort. Other studies normalized the 
superimposed stimulus to a stimulus applied 2 s after the MVC when 
the muscle response can be potentiated. Our cross-sectional study 
dataset includes both the “pre-stimulus” and the “post-stimulus” so 
we were able to compare the results. The average voluntary activa-
tion calculated for all participants pooled was 90.4% and 90.8% 
(p < .001) when using the “pre-stimulus” and the “post-stimulus”, 
respectively. It therefore made no difference to results if the pre- or 
the post-stimulus was used to normalize the superimposed stimulus.
The best estimate of the muscle quality comes from measurement 
of the in situ specific force, which takes into account the agonist muscle 
size, architecture, activation of the motor unit pool, and the patella ten-
don moment arm length. Our results show 17% lower specific force in 
old compared with young, which is similar to the findings of a previous 
study normalizing knee extensor isokinetic MVC to quadriceps ana-
tomical cross-sectional area (41). We observed no significant change in 
specific force over the 5-year follow-up in older adults. This is the first 
longitudinal study of in situ specific force accounting for patella tendon 
force, PCSA, and muscle architecture. One previous study measured 
specific force in a similar way to us, but comparing young and older 
plantar flexors. They reported that a 37% lower Achilles tendon force 
in older muscle was mostly due to a lower (30%) specific force (21). 
Their conclusion that muscle quality changes are more important than 
muscle quantity differs from our own, but closer inspection of the pub-
lished results (21) also reveals 28% lower muscle volume (21), which 
is in fact in agreement with our own findings that changes in muscle 
quantity are playing the largest role in age-related weakness.
The results of the present and a previous publication (26) reveal 
that the force/ACSA gives a very similar age-related difference as the 
more comprehensively measured in situ specific force. In situ spe-
cific force is calculated as: [Patella tendon force/(PCSA * pennation 
angle)], where the patella tendon force is the force that could be 
produced if full voluntary activation was possible. Since the moment 
arm and the voluntary activation did not differ between young 
and old, the tendon force decreased proportional to that of torque. 
Furthermore, the lower PCSA in old was mainly due to a change 
in muscle volume because the fascicle length was similar for old 
and young and age-dependent differences in pennation angle have 
minimal influence on force transmission to the tendon. Thus, the 
age-dependent differences for in situ specific force are reasonably 
estimated from force/ACSA.
In mice (42), connective tissue accumulation was associated with 
lower specific force. The small increase in connective tissue in old 
compared with young in our study explains at best just 3% of the 
difference between young and old in specific force, since connective 
tissue makes up a relatively small proportion of the overall muscle. 
The lower specific force is likely due to lower specific tension of 
individual muscle fibers in old compared with young (43–45). We 
recently reported 16% lower single fiber specific tension in old com-
pared with young (45) and this matches the estimates of the in situ 
specific force made in the present study.
The Age-Dependent Muscle Atrophy
Our results are consistent with previous reports that type II fibers 
are highly susceptible to age-related atrophy, while type I FCSA is 
well preserved (eg, see (6,7,9,46)). However, surprisingly little infor-
mation is available about muscle fiber numbers in humans and the 
scarcity of information limits current understanding of the contribu-
tions of muscle fiber changes underpinning the overall atrophy. In 
the present study, fiber atrophy accounted for 54% of the difference 
between the PCSA of young and old. The remaining 46% is pre-
sumably due to fiber losses and we estimate that the old had around 
200,000 fewer fibers than young in the VL cross section. Despite the 
selective type II atrophy, the relative area occupied by type I and type 
II fibers did not differ between young and old, which must mean that 
a greater number of type I fibers than type II is lost to balance the 
reduction in type II FCSA. These findings are in general agreement 
with data from autopsy examinations of the VL muscle, suggesting 
that loss of fibers and type II fiber atrophy both contribute to the 
loss of VL muscle mass with ageing, although the autopsy studies 
indicate similar proportional losses of type I and type II fibers (8,46).
A different conclusion was reached by Nilwick et  al. (9), who 
reported that young and old men had similar fiber numbers and that 
loss of muscle mass with ageing was due to type II fiber atrophy 
only. Notably, Nilwick et al.’s (9) older subjects were not sarcopenic 
and thus had much larger quadriceps anatomical cross-sectional 
area (QACSA: 59  cm2 in our subjects and approximately 68  cm2 
in Nilwik et  al. (9)), but similar FCSA and therefore higher fiber 
numbers than our older, sarcopenic participants. These differences 
between studies may reflect differences between sarcopenic and non-
sarcopenic old, or differences in the ageing process due to lifestyle 
and habitual activity patterns.
Our estimate of 200,000 fewer fibers in the VL cross-section of 
old compared to young is similar to Lexell et al. (8) who estimated 
about 264,000 fewer fibers in septuagenarians compared with young 
adults. Lexell’s et al. (8) data show fiber numbers decline after age 
30 years, which is the same age that muscle mass begins to decrease 
(13,18,31,32). It is highly likely that the other quadriceps muscles 
age in a similar way based on the fact that the different quadriceps 
muscles experience the same degree of atrophy (23) and undergo 
similar motor unit remodeling (47,48). Given that the VL accounts 
for about 30% of the quadriceps mass, it can be estimated that 
20,000 fibers are lost in each quadriceps muscle per year, or 40,000 
fibers across both quadriceps muscles per year, from age 30 years, 
assuming linear progressive declines. The loss of fibers may be linked 
to declining numbers of motor units, as old have 30–50% fewer 
leg motor neurons than young adults (47,49). A resistance training 
program will help to recover the type II fiber atrophy (9,50) and 
improve specific force (27), but is unlikely to recover lost fibers or 
motor units.
Conclusions
The in situ specific force declines relatively early during ageing and 
reduced voluntary activation of muscle occurs later, but the overall 
weakness in sarcopenia is mainly related to loss of both type I and 
type II muscle fibers and type II fiber atrophy.
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